Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Premarket London: Next Raises Guidance After Strong Christmas

Published 03/01/2020, 08:15
Updated 03/01/2020, 08:36
© Reuters.
BATS
-
NXT
-
RAI
-

Investing.com -- Here is a summary of the most important regulatory news releases from the London Stock Exchanges on Friday, 3rd January. Please refresh for updates.

  • Retailer Next (LON:NXT) nudged up its forecasts for full-year profit and sales after a Christmas holiday season that went marginally better than it expected.
  • The company also gave initial guidance for the year ending 2021, saying it expects per-share earnings to rise 3.5% on a 3% increase in sales on a comparable basis. For the current year, it now sees EPS at 458.7p, up 5.4% on this year.
  • In the crucial two-month period before Christmas, Next said full-price product sales rose 5.3% from last year’s levels, helped by a much colder November and improved stock availability. Sales fell 3.9% at the company’s high street stores but rose 15.3% via its online channel.
  • The company also said changes to the way the U.K. authorities collect corporate income tax mean that it will reduce the distribution of surplus cash to shareholders by 35 million pounds in the next two fiscal years, in order to keep its financial debt down.
    • British American Tobacco (LON:BATS) put a brave face on the U.S. Food and Drug Administration’s move to clamp down on flavoured vaping products, saying that it is “well positioned” to meet the new regulatory requirements.
    • BAT said its U.S. subsidiary Reynolds American (NYSE:RAI) has already filed one so-called Pre-Market Tobacco Application with the FDA and will make further applications for approval of the rest of its vapor portfolio by the May 12 deadline.
    • On Thursday, the FDA had announced a ban on sales of fruit- and mint-flavored vaping cartridges but said it would still allow those flavors to be sold from tanks in vaping shops. All vaping products will, however, need to have asked for regulatory approval by May 12.
    • The measures are thus more of a blow to those that already have such products widely available on the market than to BAT, which has lagged players such as Juul Labs and NJOY.

    Latest comments

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
    Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
    Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
    It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
    Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
    © 2007-2024 - Fusion Media Limited. All Rights Reserved.